These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8108861)
1. Is hypusine essential for eukaryotic cell proliferation? Park MH; Wolff EC; Folk JE Trends Biochem Sci; 1993 Dec; 18(12):475-9. PubMed ID: 8108861 [TBL] [Abstract][Full Text] [Related]
2. Hypusine is essential for eukaryotic cell proliferation. Park MH; Lee YB; Joe YA Biol Signals; 1997; 6(3):115-23. PubMed ID: 9285094 [TBL] [Abstract][Full Text] [Related]
3. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification. Wolff EC; Kang KR; Kim YS; Park MH Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569 [TBL] [Abstract][Full Text] [Related]
4. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Park MH; Wolff EC; Folk JE Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280 [TBL] [Abstract][Full Text] [Related]
5. Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine. Joe YA; Park MH J Biol Chem; 1994 Oct; 269(41):25916-21. PubMed ID: 7929297 [TBL] [Abstract][Full Text] [Related]
6. Marked elevation of hypusine formation activity on eukaryotic initiation factor 5A in v-HA-RAS transformed mouse NIH3T3 cells. Chen ZP; Chen KY Cancer Lett; 1997 May; 115(2):235-41. PubMed ID: 9149130 [TBL] [Abstract][Full Text] [Related]
7. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. Preukschas M; Hagel C; Schulte A; Weber K; Lamszus K; Sievert H; Pällmann N; Bokemeyer C; Hauber J; Braig M; Balabanov S PLoS One; 2012; 7(8):e43468. PubMed ID: 22927971 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the activities of variant forms of eIF-4D. The requirement for hypusine or deoxyhypusine. Park MH; Wolff EC; Smit-McBride Z; Hershey JW; Folk JE J Biol Chem; 1991 May; 266(13):7988-94. PubMed ID: 1850732 [TBL] [Abstract][Full Text] [Related]
9. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). Park MH J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303 [TBL] [Abstract][Full Text] [Related]
10. Enantiomers of 3-methylspermidine selectively modulate deoxyhypusine synthesis and reveal important determinants for spermidine transport. Hyvönen MT; Khomutov M; Petit M; Weisell J; Kochetkov SN; Alhonen L; Vepsäläinen J; Khomutov AR; Keinänen TA ACS Chem Biol; 2015 Jun; 10(6):1417-24. PubMed ID: 25689365 [TBL] [Abstract][Full Text] [Related]
12. Two isoforms of eIF-5A in chick embryo. Isolation, activity, and comparison of sequences of the hypusine-containing proteins. Wolff EC; Kinzy TG; Merrick WC; Park MH J Biol Chem; 1992 Mar; 267(9):6107-13. PubMed ID: 1556119 [TBL] [Abstract][Full Text] [Related]
13. Cellular eukaryotic initiation factor 5A content as a mediator of polyamine effects on growth and apoptosis. Tome ME; Gerner EW Biol Signals; 1997; 6(3):150-6. PubMed ID: 9285098 [TBL] [Abstract][Full Text] [Related]
14. The role of hypusine depletion in cytostasis induced by S-adenosyl-L-methionine decarboxylase inhibition: new evidence provided by 1-methylspermidine and 1,12-dimethylspermine. Byers TL; Lakanen JR; Coward JK; Pegg AE Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):363-8. PubMed ID: 7980394 [TBL] [Abstract][Full Text] [Related]
15. Hypusine modification in eukaryotic initiation factor 5A in rodent cells selected for resistance to growth inhibition by ornithine decarboxylase-inhibiting drugs. Tome ME; Gerner EW Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):55-60. PubMed ID: 8947467 [TBL] [Abstract][Full Text] [Related]
16. Diamine and triamine analogs and derivatives as inhibitors of deoxyhypusine synthase: synthesis and biological activity. Lee YB; Park MH; Folk JE J Med Chem; 1995 Aug; 38(16):3053-61. PubMed ID: 7636868 [TBL] [Abstract][Full Text] [Related]
17. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Schnier J; Schwelberger HG; Smit-McBride Z; Kang HA; Hershey JW Mol Cell Biol; 1991 Jun; 11(6):3105-14. PubMed ID: 1903841 [TBL] [Abstract][Full Text] [Related]
18. Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapy. Caraglia M; Tagliaferri P; Budillon A; Abbruzzese A Adv Exp Med Biol; 1999; 472():187-98. PubMed ID: 10736626 [TBL] [Abstract][Full Text] [Related]
19. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma. Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892 [TBL] [Abstract][Full Text] [Related]
20. The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. Caraglia M; Marra M; Giuberti G; D'Alessandro AM; Baldi A; Tassone P; Venuta S; Tagliaferri P; Abbruzzese A J Biochem; 2003 Jun; 133(6):757-65. PubMed ID: 12869532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]